KR960702754A - 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide) - Google Patents
생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide)Info
- Publication number
- KR960702754A KR960702754A KR1019950705529A KR19950705529A KR960702754A KR 960702754 A KR960702754 A KR 960702754A KR 1019950705529 A KR1019950705529 A KR 1019950705529A KR 19950705529 A KR19950705529 A KR 19950705529A KR 960702754 A KR960702754 A KR 960702754A
- Authority
- KR
- South Korea
- Prior art keywords
- physiologically active
- containing physiologically
- vaginal preparation
- preparation containing
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP93/135738 | 1993-06-07 | ||
JP13573893A JP3628713B2 (ja) | 1993-06-07 | 1993-06-07 | 生理学的に活性なペプチドを含有する膣投与製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960702754A true KR960702754A (ko) | 1996-05-23 |
KR100419558B1 KR100419558B1 (ko) | 2004-05-20 |
Family
ID=15158721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950705529A KR100419558B1 (ko) | 1993-06-07 | 1994-06-02 | 생리적으로활성인펩티드를함유하는질내투여제제 |
Country Status (9)
Country | Link |
---|---|
US (2) | US5776886A (ko) |
EP (1) | EP0702958B1 (ko) |
JP (1) | JP3628713B2 (ko) |
KR (1) | KR100419558B1 (ko) |
AU (1) | AU6856194A (ko) |
CA (1) | CA2164193C (ko) |
DE (1) | DE69427977T2 (ko) |
ES (1) | ES2161247T3 (ko) |
WO (1) | WO1994028918A1 (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3628713B2 (ja) * | 1993-06-07 | 2005-03-16 | 帝國製薬株式会社 | 生理学的に活性なペプチドを含有する膣投与製剤 |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US8765177B2 (en) * | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US7402559B2 (en) | 1999-03-24 | 2008-07-22 | Msh Pharma, Incorporated | Composition and method of treatment for urogenital conditions |
EP1251867A4 (en) | 2000-02-04 | 2004-12-08 | Unigene Lab Inc | NASAL CALCITON INFORMATION |
AT409081B (de) * | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
AU2003269747A1 (en) * | 2002-05-15 | 2003-12-02 | Sun Pharmaceutical Industries Limited | A stable aqueous composition of a peptide |
DE10248412B4 (de) * | 2002-08-01 | 2009-05-20 | Bernd Rauscher | Suppositorium zur Behandlung oder Vorbeugung von Hypoglykämie |
ATE466885T1 (de) | 2002-11-15 | 2010-05-15 | Novartis Vaccines & Diagnostic | Methoden zur verhinderung und behandlung von krebs-metastasierung und mit krebs-metastasierung einhergehendem knochenverlust |
MXPA06013168A (es) * | 2004-05-13 | 2007-05-15 | Johnson & Johnson | Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea. |
US8088093B2 (en) * | 2008-08-07 | 2012-01-03 | Ottuso Patrick | Wound penetrating hemostatic device impregnated with coagulant, antibiotic and/or anesthetic |
JP2012509251A (ja) | 2008-08-29 | 2012-04-19 | ジェンザイム・コーポレーション | 放出制御ペプチド製剤 |
AU2011218154A1 (en) * | 2010-02-16 | 2012-09-06 | Playtex Products,Llc | Low pH, optimal ORP, and odor-reducing fibers, a process for making the fibers, and articles made therefrom |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59148717A (ja) * | 1983-02-11 | 1984-08-25 | Takeda Chem Ind Ltd | 膣投与製剤 |
JPS6210020A (ja) * | 1985-07-08 | 1987-01-19 | Kanebo Ltd | カルシトニン含有組成物 |
JPS62267238A (ja) * | 1986-05-15 | 1987-11-19 | R P Shiila- Kk | インシユリン坐剤の製法 |
JPS6339822A (ja) * | 1986-08-04 | 1988-02-20 | Yamanouchi Pharmaceut Co Ltd | カルシトニン経鼻剤 |
JPH01230530A (ja) * | 1987-11-21 | 1989-09-14 | Toyo Jozo Co Ltd | カルシトニン類経鼻投与用液剤組成物 |
NZ228285A (en) * | 1988-03-11 | 1991-08-27 | Teikoku Seiyaku Kk | Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration |
JPH0348627A (ja) * | 1989-07-14 | 1991-03-01 | Kanebo Ltd | カルシトニン腟坐剤 |
JPH0381228A (ja) * | 1989-08-24 | 1991-04-05 | Kanebo Ltd | カルシトニン腟坐剤 |
JPH04149126A (ja) * | 1990-10-09 | 1992-05-22 | Mitsubishi Kasei Corp | 経粘膜投与用医薬組成物 |
AU653026B2 (en) * | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
CA2094217A1 (en) * | 1992-04-17 | 1993-10-18 | Yasutaka Igari | Transmucosal therapeutic composition |
JP3628713B2 (ja) * | 1993-06-07 | 2005-03-16 | 帝國製薬株式会社 | 生理学的に活性なペプチドを含有する膣投与製剤 |
-
1993
- 1993-06-07 JP JP13573893A patent/JP3628713B2/ja not_active Expired - Fee Related
-
1994
- 1994-06-02 ES ES94917146T patent/ES2161247T3/es not_active Expired - Lifetime
- 1994-06-02 US US08/557,104 patent/US5776886A/en not_active Expired - Lifetime
- 1994-06-02 WO PCT/JP1994/000894 patent/WO1994028918A1/ja active IP Right Grant
- 1994-06-02 KR KR1019950705529A patent/KR100419558B1/ko not_active IP Right Cessation
- 1994-06-02 AU AU68561/94A patent/AU6856194A/en not_active Abandoned
- 1994-06-02 DE DE69427977T patent/DE69427977T2/de not_active Expired - Fee Related
- 1994-06-02 EP EP94917146A patent/EP0702958B1/en not_active Expired - Lifetime
- 1994-06-02 CA CA002164193A patent/CA2164193C/en not_active Expired - Fee Related
-
1998
- 1998-01-21 US US09/009,734 patent/US6008189A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5776886A (en) | 1998-07-07 |
AU6856194A (en) | 1995-01-03 |
DE69427977T2 (de) | 2001-11-29 |
JP3628713B2 (ja) | 2005-03-16 |
WO1994028918A1 (fr) | 1994-12-22 |
CA2164193C (en) | 2007-09-18 |
KR100419558B1 (ko) | 2004-05-20 |
ES2161247T3 (es) | 2001-12-01 |
EP0702958A4 (en) | 1996-12-04 |
DE69427977D1 (de) | 2001-09-20 |
JPH06345665A (ja) | 1994-12-20 |
EP0702958A1 (en) | 1996-03-27 |
EP0702958B1 (en) | 2001-08-16 |
US6008189A (en) | 1999-12-28 |
CA2164193A1 (en) | 1994-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0845265A4 (en) | PREPARATION FOR MUCUSA BASED ON PEPTIDES WITH PHYSIOLOGICAL ACTIVITY | |
DE4393381T1 (de) | Peptide | |
EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
TR199501669A1 (tr) | Peptid ve proteinlerin aerosol formülasyonlari. | |
DE69001876D1 (de) | Hoch-resorbierbare transvaginale zubereitung mit biologisch aktiven peptiden. | |
DE69626397D1 (de) | Darifenacin enthaltende pharmazeutische zubereitungen | |
ATA144090A (de) | Formulierungen mit verlangsamter freisetzung wasserlöslicher peptide | |
AU6360394A (en) | Vasonatrin peptide and analogs thereof | |
AU7305594A (en) | Physiologically active substance-prolonged releasing-type pharmaceutical preparation | |
ATA901092A (de) | Teilchen enthaltend biologisch aktives peptid | |
DK6893D0 (da) | Peptid | |
IL89804A0 (en) | Biologically active proteins | |
HU907939D0 (en) | Stabilized aqueous formulations of small peptides | |
KR960702754A (ko) | 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide) | |
EP0340333A3 (en) | Novel physiologically active polypeptide and pharmaceutical composition | |
HRP950612B1 (en) | PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | |
DE69711267T2 (de) | Cyclosporin enthaltende Weichkapselpräparate | |
AU6428890A (en) | Therapeutic peptides and proteins | |
DE69617396D1 (de) | T-Zellen beeinflussende Peptide | |
ZA936692B (en) | Physiologically active peptide composition | |
EP0129582A4 (en) | BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION. | |
DE69427363D1 (de) | Plättchenaggregationsinhibierende peptide | |
EP0450100A4 (en) | Physiologically active peptide | |
AU8769791A (en) | Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence | |
AU6156294A (en) | Physiologically active peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20091230 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |